Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy

by Keith D. Eaton, Christina S. Baik
Published 2012-09-01

Plasma processing conditions substantially influence circulating microRNA biomarker levels.

by Heather H Cheng, Hye Son Yi, Yeonju Kim, Evan M Kroh, Jason W Chien, Keith D Eaton, Marc T Goodman, Jonathan F Tait, Muneesh Tewari, Colin C Pritchard
Published 2013-01-01

Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma

by Sara Bedrose, Kevin Charles Miller, Lina Altameemi, Mohamed S Ali, Sameh Nassar, Naveen Garg, Marilyne Daher, Keith D Eaton, Jeffrey Thomas Yorio, Davey B Daniel, Keith C Bible, Ashish V Chintakuntlawar, Mouhammed Amir Habra
Published 2020-07-01

Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma

by Sara Bedrose, Kevin Charles Miller, Lina Altameemi, Mohamed S Ali, Sameh Nassar, Naveen Garg, Marilyne Daher, Keith D Eaton, Jeffrey Thomas Yorio, Davey B Daniel, Keith C Bible, Ashish V Chintakuntlawar, Mouhammed Amir Habra
Published 2020-07-01

Correction: On the mechanism of anti-CD39 immune checkpoint therapy

by Sara Bedrose, Kevin Charles Miller, Lina Altameemi, Mohamed S Ali, Sameh Nassar, Naveen Garg, Marilyne Daher, Keith D Eaton, Jeffrey Thomas Yorio, Davey B Daniel, Keith C Bible, Ashish V Chintakuntlawar, Mouhammed Amir Habra
Published 2020-07-01

Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome

by Perrin E. Romine, Renato G. Martins, Keith D. Eaton, Douglas E. Wood, Fatemeh Behnia, Bernardo H. L. Goulart, Michael S. Mulligan, Sarah G. Wallace, Elizabeth Kell, Julie E. Bauman, Shilpen A. Patel, Hubert J. Vesselle
Published 2019-01-01